scholarly journals The Quality of life of patients with morbid obesity before and after gastric banding and gastric bypass

2014 ◽  
Vol 11 (2) ◽  
pp. 13-16
Author(s):  
V Egiev ◽  
J Majorova ◽  
M Leont’yeva ◽  
A Meleshko

In order to estimate the quality of life in bariatric surgery patients usually two scales are used: GIQLI (gastrointestinal Quality of life index) and BAROS (Bariatric analysis and reporting outcome system). In our work we used the original estimation of the quality of life, based on the questionnaire GIQLI. This questionnaire consists of two parts: universal and specific. For the estimation of the level of morbid obesity two main scores are utilized: overweight and the Body Mass Index (BMI). We estimated the quality of life of patients with morbid obesity before the operation (25 patients), after gastric banding (25 patients) and gastric bypass (25 patients). For the control group we show the answers for the same questionnaire of 26 volunteers without any chronic diseases, including morbid obesity. Gastric bypass was performed in patients with BMI more than 40 kg/m2, gastric banding was performed in patients with BMI less than 40 kg/m2. The median periods of supervising the patients after gastric bypass and gastric banding were 3±1,9 years and 4,3±1,7 years for each. After the surgery the percentage of reduction of the overweight was significantly higher in the patients after the gastric bypass. It means that the weight loss is more effective after gastric bypass than gastric banding. The index of the quality of life of the patients with the morbid obesity was much lower than in the control group (р0,05). After the surgical treatment all the scores increased in the group of the patients being operated on, than in the group of the patients with obesity before the operations (р0,05). While comparatively estimating the two operations we got practically the same results after gastric bypass and gastric banding. For gastric banding a very important index of the improvement of the quality of life is the level of the weight loss, but after the gastric bypass there were no such outcome.

Obesity Facts ◽  
2010 ◽  
Vol 3 (2) ◽  
pp. 4-4 ◽  
Author(s):  
Junilla K. Larsen ◽  
Hanna Zijlstra ◽  
Bert van Ramshort ◽  
Rinie Geenen

2005 ◽  
Vol 15 (8) ◽  
pp. 1177-1184 ◽  
Author(s):  
E. Mamplekou ◽  
V. Komesidou ◽  
Ch. Bissias ◽  
A. Papakonstantinou ◽  
J. Melissas

2014 ◽  
Vol 51 (4) ◽  
pp. 320-327 ◽  
Author(s):  
Maria Ignez Xavier de Toledo DUARTE ◽  
Debora Pastore BASSITT ◽  
Otávio Cansanção de AZEVEDO ◽  
Jaques WAISBERG ◽  
Nagamassa YAMAGUCHI ◽  
...  

Context Few studies have evaluated the results of different types of bariatric surgery using the Medical Outcome Study 36 - Health Survey Short-Form (SF-36) quality of life questionnaire, the Bariatric and Reporting Outcome System (BAROS) and the reviewed Moorehead-Ardelt Quality of Life II Questionnaire (M-A QoLQ II) that is part of BAROS. The Roux-en-Y gastric bypass (RYGB) is the most common morbid obesity surgery worldwide. However, there is evidence indicating that a biliopancreatic diversion with duodenal switch (DS) is more effective than RYGB in weight loss terms. Objectives To evaluate the impact of different types of bariatric surgery on quality of life, comorbidities and weight loss. Methods Two groups of patients who underwent bariatric surgery conventional Banded Roux-en-Y gastric bypass (BRYGB) or DS were evaluated through monitoring at 12 to 36 months after surgery, as well as a control group of obese patients who had not undergone surgery. The tools used for this were SF-36, BAROS and M-A QoLQ II. The DS group consisted of 17 patients and the BRYGB group consisted of 20. The control group comprised 20 independent, morbidly obese individuals. Results The mean age of the patients in the groups was 45.18 in the DS group, 49.75 in the BRYGB group and 44.25 in the control group, with no significant difference. There was no difference in the ratio of men to women in the groups. The patients that had surgery showed a significant improvement in all domains of quality of life vs the control group. Comparing the two groups that underwent surgery, the DS group achieved better quality of life results in terms of “general state of health” and “pain”, according to responses to the SF-36 tool, and in terms of “sexual interest”, according to responses to the M-A QoLQ II tool. There was no significant difference among the three groups regarding the ratio of occurrence of comorbidities. In the groups that had surgery, the resolution of comorbidities was similar. The final classification according to the BAROS Protocol was excellent for the DS group and very good for the BRYGB group, with a statistical difference in favor of the DS group (P = 0.044*). There was no difference in the percentages of excess weight loss between the DS group (82.1%) and the BRYGB group (89.4%) (P = 0.376). Conclusions A comparison of the performance of the groups, which were monitored from 12 to 36 months after surgery, showed that the two types of surgery are effective to improve quality of life, comorbidities and weight loss. The DS surgery produced better results in the quality of life evaluations regarding 2 of 8 domains according to the SF-36, and “sexual interest” according to the M-A QoLQ II. In the groups that had surgery, the patients showed high rates of comorbidity resolution. Weight loss was similar for the two surgical groups.


2015 ◽  
Vol 12 (2) ◽  
pp. 20-23
Author(s):  
Valeriy Nikolaevich Egiev ◽  
Yuliya Borisovna Mayorova ◽  
Evgeniy Aleksandrovich Zorin ◽  
Anastasiya Vladimirovna Meleshko ◽  
Ekaterina Sergeevna Orlovskaya

The main goal of any surgical intervention in morbid obesity is to improve the quality of life of patients which is considered directly related to the loss of excess body weight and a reduction in the incidence of related diseases. The aim of this study was to determine the interdependence of these indicators. In 2005-2013 we performed 457 operations of gastric banding (GB) and 198 - gastric bypass (GBP). After GB only body mass index (BMI) and quality of life index (QOL) had significant linear correlation, i.e., the higher the weight of the patient, the worse the quality of life. After GBP there was is a significant linear relationship only between the patient's body weight and dynamics of comorbidities, i.e. the higher the weight of the patient, the higher the level of comorbidity. The QOL of patients after GBP does not depend on the body weight or on the frequency of comorbidities.


2013 ◽  
Vol 144 (5) ◽  
pp. S-268
Author(s):  
Nam Q. Nguyen ◽  
Tamara L. Debreceni ◽  
Melissa Neo ◽  
Trehan K. Dinesh ◽  
Philip A. Game ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document